| PHUSE US |
2024 |
Real-World Data - What is Fit for Purpose? [poster] |
Berber Snoeijer |
source |
1 |
| PHUSE US |
2024 |
Usage of OMOP-CDM along with CDISC in Clinical Trials: Challenges and Opportunities |
|
source
presentation source |
5 |
| PharmaSUG |
2022 |
Vendor Audit: What it is and What to Expect from it |
Nagadip Rao |
source |
6 |
| PHUSE US |
2022 |
Navigation of Professional Development Planning Through the Performance Appraisal Process [presentation] |
|
source
video |
13 |
| PHUSE EU |
2016 |
Planning for Data Reporting Processes for Submission: Key Considerations |
|
source
presentation source |
2 |
| PharmaSUG |
2013 |
Deployment of SAS Programming Contract Staff: Pathway to Sinkhole or Best Strategy for Programming Division? |
|
source |
5 |
| NESUG |
2012 |
Quality Assurance: Best Practices in Clinical SAS Programming |
|
|
8 |
| PharmaSUG |
2011 |
Efficiencies Realized in Building and Utilizing ADaM from SDTM |
Shirish Nalavade |
source |
5 |
| PharmaSUG |
2010 |
CDASH Standards for Medical Device Trials: CRF Analysis |
Jennie Tedrow,
Kit Howard,
Laura Fazio,
Daniela Luzi,
Rhonda Facile |
|
8 |
| PharmaSUG |
2010 |
Programming Validation: Perspectives and Strategies |
|
|
4 |
| SGF |
2009 |
Clinical SAS Programming: Analysis and Mitigation of Risk |
|
source |
6 |
| PharmaSUG |
2008 |
Performance Evaluation of Clinical SAS Programmer |
|
|
6 |
HOME
QUICK SEARCH
AUTHORS
KEYWORDS
HELP
BUGS